M1393 — Patients who were not diagnosed with recurrent melanoma during the current performance period
M1393 is a HCPCS Level II code for patients who were not diagnosed with recurrent melanoma during the current performance period. It belongs to the Medical Services section. Whether Medicare pays it depends on the coverage rule below.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
Physician fee schedule statusM
Measurement code. Used for reporting purposes only; never paid.
Global period: XXX
Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.
The CMS record for M1393
- Long descriptor
- Patients who were not diagnosed with recurrent melanoma during the current performance period
- Short descriptor
- Pr no dx rec mlnm
- Added
- January 1, 2025
- BETOS
- Z2
- Pricing indicator
- 00 — Not priced by Part B
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Service not separately priced by Part B — not covered, bundled into another service, or used by Part A only.
Codes adjacent to M1393
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If M1393 is not quite right, the correct code is very often within a few positions of it.
- M1384Patients who died during the performance period
- M1385Documentation of patient reasons for patients who were not seen for the second pam survey (e.g., less than four months between baseline pam assessment and follow-up
- M1386Patients with an excisional surgery for melanoma or melanoma in situ in the past 5 years with an initial ajcc staging of 0, i, or ii at the start of the performance period
- M1387Patients who died during the performance period
- M1388Patients with documentation of an exam performed for recurrence of melanoma
- M1390Patients who do not have a documented exam performed for recurrence of melanoma or no documentation within the performance period
- M1391All patients who were diagnosed with recurrent melanoma during the current performance period
- M1392Documentation of patient reasons for no examination, i.e., refusal of examination or lost to follow-up (documentation must include information that the clinician was unable to reach the patient by phone, mail or secure electronic mail - at least one method must be documented)
- M1394Stages i-iii breast cancer
- M1395Patients receiving an initial chemotherapy regimen with a defined duration with the eligible clinician or group
- M1396Patients on a therapeutic clinical trial
- M1397Patients with recurrence/disease progression
- M1398Patients with baseline and follow-up promis surveys documented in the medical record
- M1399Patients who leave the practice during the follow-up period
- M1400Patients who died during the follow-up period
- M1401Stages i-iii breast cancer
Questions about M1393
What is HCPCS code M1393?
M1393 is a HCPCS Level II code for patients who were not diagnosed with recurrent melanoma during the current performance period. It sits in the Medical Services section.
Does Medicare cover M1393?
The CMS HCPCS file marks M1393 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
How is M1393 paid under the physician fee schedule?
M1393 carries PFS status code M. Measurement code. Used for reporting purposes only; never paid.